GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shijiazhuang Yiling Pharmaceutical Co Ltd (SZSE:002603) » Definitions » Days Payable

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Days Payable : 207.16 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shijiazhuang Yiling Pharmaceutical Co Days Payable?

Shijiazhuang Yiling Pharmaceutical Co's average Accounts Payable for the three months ended in Mar. 2024 was ¥2,779 Mil. Shijiazhuang Yiling Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥1,224 Mil. Hence, Shijiazhuang Yiling Pharmaceutical Co's Days Payable for the three months ended in Mar. 2024 was 207.16.

The historical rank and industry rank for Shijiazhuang Yiling Pharmaceutical Co's Days Payable or its related term are showing as below:

SZSE:002603' s Days Payable Range Over the Past 10 Years
Min: 65.87   Med: 97.39   Max: 231.93
Current: 231.93

During the past 13 years, Shijiazhuang Yiling Pharmaceutical Co's highest Days Payable was 231.93. The lowest was 65.87. And the median was 97.39.

SZSE:002603's Days Payable is ranked better than
85.32% of 974 companies
in the Drug Manufacturers industry
Industry Median: 87.51 vs SZSE:002603: 231.93

Shijiazhuang Yiling Pharmaceutical Co's Days Payable increased from Mar. 2023 (160.48) to Mar. 2024 (207.16). It may suggest that Shijiazhuang Yiling Pharmaceutical Co delayed paying its suppliers.


Shijiazhuang Yiling Pharmaceutical Co Days Payable Historical Data

The historical data trend for Shijiazhuang Yiling Pharmaceutical Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shijiazhuang Yiling Pharmaceutical Co Days Payable Chart

Shijiazhuang Yiling Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.62 99.21 139.30 147.99 203.18

Shijiazhuang Yiling Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 160.48 211.30 316.55 220.80 207.16

Competitive Comparison of Shijiazhuang Yiling Pharmaceutical Co's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Shijiazhuang Yiling Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shijiazhuang Yiling Pharmaceutical Co's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shijiazhuang Yiling Pharmaceutical Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Shijiazhuang Yiling Pharmaceutical Co's Days Payable falls into.



Shijiazhuang Yiling Pharmaceutical Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Shijiazhuang Yiling Pharmaceutical Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (2060.776 + 2846.544) / 2 ) / 4407.809*365
=2453.66 / 4407.809*365
=203.18

Shijiazhuang Yiling Pharmaceutical Co's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (2846.544 + 2711.241) / 2 ) / 1224.061*365 / 4
=2778.8925 / 1224.061*365 / 4
=207.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shijiazhuang Yiling Pharmaceutical Co Days Payable Related Terms

Thank you for viewing the detailed overview of Shijiazhuang Yiling Pharmaceutical Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Business Description

Traded in Other Exchanges
N/A
Address
No. 7 Tianfu street, Biology and medicine industrial base, Huangcun town, Daxing district, Beijing, CHN
Shijiazhuang Yiling Pharmaceutical Co Ltd is a China-based company engages in the pharmaceutical manufacturing. The company is principally engaged in the research, development, manufacturing, and sales of traditional Chinese pharmaceutical products, especially in the fields of cardiovascular and cerebrovascular diseases, respiratory diseases, tumor, diabetes and related complications. Its products include innovative drug series, chemical drugs, Chinese medicine series, and health products.

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Headlines

No Headlines